封面
市場調查報告書
商品編碼
1866414

全球導管市場-2025-2030年預測

Global Catheters Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球導管市場預計將從 2025 年的 345.89 億美元成長到 2030 年的 492.17 億美元,複合年成長率為 7.31%。

未來五年,全球導尿管市場預計將保持強勁成長,主要促進因素包括心血管疾病和泌尿系統疾病等慢性病盛行率的上升以及人口快速老化。導尿管是由矽橡膠、聚氯乙烯(PVC)和尼龍等材料製成的細管,在醫療保健領域中發揮至關重要的治療和診斷作用。住院患者數量的增加以及對微創手術需求的成長是推動市場發展的因素。然而,導尿管相關感染疾病(例如尿道感染(CAUTI)和中央靜脈導管相關血流感染疾病(CLABSI))以及先前疫情造成的干擾等挑戰仍然是阻礙因素,因此需要技術創新來降低風險並提高患者安全。

市場促進因素

不健康的生活方式導致慢性疾病的增加是推動導尿管需求成長的主要因素,其中心血管疾病和腎臟疾病特別突出。根據聯合國預測,到2050年,65歲及以上人口將佔世界人口的16%,人口老化顯著推高了導尿管的需求,因為越來越多的老年人更容易患上需要使用導尿管的疾病,例如尿失禁和癌症。此外,因各種治療而住院的患者人數不斷增加,也進一步推高了導尿管的需求,尤其是在醫療服務水準不斷提高的已開發國家和開發中國家。旨在透過先進材料和設計降低感染風險的創新也推動了市場成長。

市場限制

長期使用導尿管會增加感染風險,例如導尿管相關尿道感染(CAUTI) 和導尿管相關血流感染疾病(CLABSI),這引發了患者的抵觸情緒,限制了市場接受度。先進導尿管技術的高成本也可能限制低收入地區的病患使用。此外,過去全球衛生危機導致擇期手術和住院治療中斷,暫時影響了市場需求,凸顯了建立穩健供應鏈和製定感染防治策略的必要性。

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 全球導管市場(按類型分類)

  • 介紹
  • 間歇性導尿管
  • 留置導管
  • 外導管
  • 心血管導管
  • 靜脈導管
  • 神經血管導管
  • 透析導管
  • 消化道導管
  • 呼吸導管
  • 植入式導管
  • 其他

6. 全球導管市場(依最終用戶分類)

  • 介紹
  • 醫院
  • 診所
  • 診斷與介入放射中心
  • 門診手術中心
  • 居家醫療
  • 長期照護機構
  • 復健中心
  • 其他

7. 全球導管市場(依地區分類)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第8章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第9章:公司簡介

  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Abbott
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation
  • Medtronic
  • ConvaTec Group
  • Johnson & Johnson Services
  • Stryker
  • Terumo Corporation

第10章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061614012

The Global Catheters Market will surge from USD 34.589 billion in 2025 to USD 49.217 billion in 2030, registering a 7.31% compound annual growth rate (CAGR).

The global catheters market is poised for robust growth over the next five years, driven by the rising prevalence of chronic diseases, such as cardiovascular diseases and urological disorders, and a rapidly aging population. Catheters, thin tubes made from materials like silicone rubber, PVC, and nylon, are critical for therapeutic and diagnostic purposes in medical settings. The market is fueled by increasing hospitalizations and the growing need for minimally invasive procedures. However, challenges such as catheter-associated infections, including urinary tract infections (CAUTIs) and central line-associated bloodstream infections (CLABSIs), and disruptions from past pandemics pose restraints, necessitating innovation to mitigate risks and enhance patient safety.

Market Drivers

The escalating burden of chronic diseases, driven by unhealthy lifestyles, is a primary driver, with cardiovascular diseases and kidney disorders increasing demand for catheters. The aging global population, projected to reach 16% aged 65 and older by 2050 (United Nations), significantly boosts demand, as elderly individuals are more prone to conditions requiring catheters, such as urinary incontinence and cancer. Rising hospitalizations for various treatments further amplify the need for catheters, particularly in developed and developing economies with improving healthcare access. Innovations aimed at reducing infection risks through advanced materials and designs are also driving market growth.

Market Constraints

Prolonged catheter use raises concerns about infections like CAUTIs and CLABSIs, leading to patient reluctance and limiting market adoption. High costs of advanced catheter technologies may restrict access in low-income regions. Additionally, disruptions in elective surgeries and hospitalizations due to past global health crises have temporarily impacted demand, highlighting the need for resilient supply chains and infection-mitigation strategies.

Market Segmentation

The catheters market is segmented by type, end-user, and geography. Types include cardiovascular, urological, indwelling, intermittent, specialty, and implantable catheters, with cardiovascular and urological catheters leading due to high disease prevalence. End-users encompass hospitals, clinics, diagnostic imaging centers, and others, with hospitals dominating due to high patient volumes. Geographically, the market spans North America, Europe, Asia Pacific, South America, and the Middle East and Africa, with growth driven by regional healthcare needs and infrastructure.

Geographical Outlook

The Asia Pacific region is expected to witness strong growth, driven by the high prevalence of chronic diseases in countries like India and China, fueled by unhealthy lifestyles and aging populations. North America holds a significant share, supported by advanced healthcare infrastructure and the presence of major market players. Europe, South America, and the Middle East and Africa are projected to experience steady growth as healthcare access improves.

Competitive Landscape

Key players, including Boston Scientific, Medtronic, and Abbott, focus on R&D to develop advanced catheters with enhanced materials to reduce infection risks. Strategic partnerships and product launches are common to address evolving healthcare needs and maintain competitive advantages.

Opportunities and Challenges

Opportunities lie in expanding innovative catheter designs and targeting high-growth regions with rising healthcare demands. Challenges include mitigating infection risks and addressing cost barriers in developing markets. Industry experts should prioritize infection-resistant technologies and scalable solutions to capitalize on the catheters market's growth potential in a health-conscious global landscape.

The Catheters Market is analyzed into the following segments:

By Type

  • Intermittent Catheters
  • Indwelling Catheters
  • External Catheters
  • Cardiovascular Catheters
  • Intravenous Catheters
  • Neurovascular Catheters
  • Dialysis Catheters
  • Gastrointestinal Catheters
  • Respiratory Catheters
  • Implantable Catheters
  • Others

By End-User

  • Hospitals
  • Clinics
  • Diagnostic and Interventional Radiology Centers
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Long-Term Care Facilities
  • Rehabilitation Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CATHETERS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Intermittent Catheters
  • 5.3. Indwelling Catheters
  • 5.4. External Catheters
  • 5.5. Cardiovascular Catheters
  • 5.6. Intravenous Catheters
  • 5.7. Neurovascular Catheters
  • 5.8. Dialysis Catheters
  • 5.9. Gastrointestinal Catheters
  • 5.10. Respiratory Catheters
  • 5.11. Implantable Catheters
  • 5.12. Others

6. GLOBAL CATHETERS MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Clinics
  • 6.4. Diagnostic and Interventional Radiology Centers
  • 6.5. Ambulatory Surgical Centers
  • 6.6. Home Care Settings
  • 6.7. Long-Term Care Facilities
  • 6.8. Rehabilitation Centers
  • 6.9. Others

7. GLOBAL CATHETERS MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Boston Scientific Corporation
  • 9.2. B. Braun Melsungen AG
  • 9.3. Abbott
  • 9.4. Teleflex Incorporated
  • 9.5. Edwards Lifesciences Corporation
  • 9.6. Medtronic
  • 9.7. ConvaTec Group
  • 9.8. Johnson & Johnson Services
  • 9.9. Stryker
  • 9.10. Terumo Corporation

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key benefits for the stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations